BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12411766)

  • 1. Predictors of course and outcome in hypochondriasis after cognitive-behavioral treatment.
    Hiller W; Leibbrand R; Rief W; Fichter MM
    Psychother Psychosom; 2002; 71(6):318-25. PubMed ID: 12411766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of hypochondriacal patients with chronic low-back pain to cognitive-behavioral therapy.
    Nakao M; Shinozaki Y; Nolido N; Ahern DK; Barsky AJ
    Psychosomatics; 2012; 53(2):139-47. PubMed ID: 22424162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimensional and categorical approaches to hypochondriasis.
    Hiller W; Rief W; Fichter MM
    Psychol Med; 2002 May; 32(4):707-18. PubMed ID: 12102385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Characteristics and Patient Behavior as Predictors of Outcome in Cognitive Therapy and Exposure Therapy for Hypochondriasis.
    Richtberg S; Jakob M; Höfling V; Weck F
    J Clin Psychol; 2017 Jun; 73(6):612-625. PubMed ID: 27532367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the effect of psychoeducational group treatment for hypochondriasis.
    Buwalda FM; Bouman TK
    Clin Psychol Psychother; 2008; 15(6):396-403. PubMed ID: 19115458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The course of transient hypochondriasis.
    Barsky AJ; Cleary PD; Sarnie MK; Klerman GL
    Am J Psychiatry; 1993 Mar; 150(3):484-8. PubMed ID: 8434667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating hypochondriasis from panic disorder.
    Hiller W; Leibbrand R; Rief W; Fichter MM
    J Anxiety Disord; 2005; 19(1):29-49. PubMed ID: 15488366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypochondriasis and somatization: two distinct aspects of somatoform disorders?
    Leibbrand R; Hiller W; Fichter MM
    J Clin Psychol; 2000 Jan; 56(1):63-72. PubMed ID: 10661369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety as a predictor of improvements in somatic symptoms and health anxiety associated with cognitive-behavioral intervention in hypochondriasis.
    Nakao M; Shinozaki Y; Ahern DK; Barsky AJ
    Psychother Psychosom; 2011; 80(3):151-8. PubMed ID: 21372623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective 4- to 5-year study of DSM-III-R hypochondriasis.
    Barsky AJ; Fama JM; Bailey ED; Ahern DK
    Arch Gen Psychiatry; 1998 Aug; 55(8):737-44. PubMed ID: 9707385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cognitive-behavioral group therapy for patients with hypochondriasis (health anxiety).
    Weck F; Gropalis M; Hiller W; Bleichhardt G
    J Anxiety Disord; 2015 Mar; 30():1-7. PubMed ID: 25589453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hypochondriasis with the Illness Attitude Scales.
    Weck F; Bleichhardt G; Hiller W
    J Pers Assess; 2010 May; 92(3):260-8. PubMed ID: 20408026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A community-based psychoeducational group approach to hypochondriasis.
    Bouman TK
    Psychother Psychosom; 2002; 71(6):326-32. PubMed ID: 12411767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive aspects of hypochondriasis and the somatization syndrome.
    Rief W; Hiller W; Margraf J
    J Abnorm Psychol; 1998 Nov; 107(4):587-95. PubMed ID: 9830246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis.
    Fallon BA; Ahern DK; Pavlicova M; Slavov I; Skritskya N; Barsky AJ
    Am J Psychiatry; 2017 Aug; 174(8):756-764. PubMed ID: 28659038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up.
    Greeven A; van Balkom AJ; van der Leeden R; Merkelbach JW; van den Heuvel OA; Spinhoven P
    J Behav Ther Exp Psychiatry; 2009 Sep; 40(3):487-96. PubMed ID: 19616195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of hypochondriacal personality disorder.
    Tyrer P; Seivewright N; Seivewright H
    J Psychosom Res; 1999 Feb; 46(2):177-85. PubMed ID: 10098826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanatory therapy in hypochondriasis.
    Fava GA; Grandi S; Rafanelli C; Fabbri S; Cazzaro M
    J Clin Psychiatry; 2000 Apr; 61(4):317-22; quiz 323. PubMed ID: 10830159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial.
    Hedman E; Ljótsson B; Andersson E; Rück C; Andersson G; Lindefors N
    Cogn Behav Ther; 2010; 39(4):239-50. PubMed ID: 20972912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of remission in DSM hypochondriasis.
    Barsky AJ; Bailey ED; Fama JM; Ahern DK
    Compr Psychiatry; 2000; 41(3):179-83. PubMed ID: 10834626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.